Literature DB >> 12824837

Chorioretinal lesions in patients with chronic granulomatous disease.

Seong-Joon Kim1, Joong Gon Kim, Young Suk Yu.   

Abstract

PURPOSE: To describe the frequency and clinical characteristics of chorioretinal lesions as a complication of chronic granulomatous disease (CGD).
METHODS: Seventeen patients with CGD examined at Seoul National University Children's Hospital between 1996 and 1999 were recruited for this study. A review of their historical, clinical, and fluorescein angiographic features was performed, and the prevalence and demographic and clinical features of the chorioretinal lesions were summarized.
RESULTS: Chorioretinal lesions were identified in 11 eyes of six patients with CGD, an overall prevalence of 35.3%. Patients' ages ranged from 6 months to 10 years, with a median of 47.0 months. Three of the six patients were boys. The lesions included RPE atrophy or pigment clumping, chorioretinal atrophy. Among the six patients, two had vision loss because of ischemia in the peripheral retina, neovascular membrane, and macular edema, which had not been previously reported.
CONCLUSIONS: Chorioretinal lesions are not uncommon in patients with CGD and they may affect vision. Regular screening of patients with CGD and long-term follow-up of CGD chorioretinopathy patients should be performed to define the lesion, natural history, and pathogenesis.

Entities:  

Mesh:

Year:  2003        PMID: 12824837     DOI: 10.1097/00006982-200306000-00012

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  10 in total

1.  Chorioretinal lesions as the unique feature of complete chronic granulomatous disease in an 8-year-old girl.

Authors:  Martin Chalumeau; Dominique Monnet; Antoine P Brézin; Dominique Gendrel; Jean-Laurent Casanova; Bénédicte Gérard; Sylvie Chollet-Martin
Journal:  Eur J Pediatr       Date:  2007-01-04       Impact factor: 3.183

2.  Chronic granulomatous disease and neovascularisation causing a vitreous haemorrhage.

Authors:  Julia Baxter; Ravikiran Gandhewar; Roger Holden
Journal:  BMJ Case Rep       Date:  2010-12-29

Review 3.  Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.

Authors:  A C Battersby; A M Cale; D Goldblatt; A R Gennery
Journal:  J Clin Immunol       Date:  2013-11       Impact factor: 8.317

4.  Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice.

Authors:  Qiuhong Li; Astra Dinculescu; Zhiying Shan; Rehae Miller; Jijing Pang; Alfred S Lewin; Mohan K Raizada; William W Hauswirth
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

Review 5.  NOX enzymes and diabetic complications.

Authors:  Tomoko Kakehi; Chihiro Yabe-Nishimura
Journal:  Semin Immunopathol       Date:  2008-05-17       Impact factor: 9.623

6.  Chronic granulomatous disease presenting as retinal mass.

Authors:  Ahmad M Mansour; Mays Al Dairy; Rola Hamam; Ahmed A Hidayat
Journal:  Cases J       Date:  2008-10-21

Review 7.  Inflammatory manifestations in chronic granulomatous disease (CGD).

Authors:  S D Rosenzweig
Journal:  J Clin Immunol       Date:  2008-01-12       Impact factor: 8.317

8.  Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease.

Authors:  Yujuan Wang; Beatriz E Marciano; Defen Shen; Rachel J Bishop; Stanley Park; Steven M Holland; Chi-Chao Chan
Journal:  J Clin Immunol       Date:  2013-05-01       Impact factor: 8.317

Review 9.  Ocular involvement in primary immunodeficiency diseases.

Authors:  Sima Hosseinverdi; Hassan Hashemi; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2013-11-30       Impact factor: 8.542

10.  Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.

Authors:  Alessandra Magnani; Nizar Mahlaoui
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.930

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.